N-arachidonoyl glycine, an endogenous lipid that acts as a vasorelaxant via nitric oxide and large conductance calcium-activated potassium channels.
about
N-Arachidonyl glycine does not activate G protein-coupled receptor 18 signaling via canonical pathwaysVascular targets for cannabinoids: animal and human studiesThe cannabinoid acids, analogs and endogenous counterpartsInternational Union of Basic and Clinical Pharmacology. LXXIX. Cannabinoid receptors and their ligands: beyond CB₁ and CB₂N-arachidonyl-glycine modulates synaptic transmission in superficial dorsal hornResolution of inflammation by N-arachidonoylglycine.N-Amino acid linoleoyl conjugates: anti-inflammatory activitiesPharmacological profiling of the hemodynamic effects of cannabinoid ligands: a combined in vitro and in vivo approachN-Arachidonoyl glycine suppresses Na⁺/Ca²⁺ exchanger-mediated Ca²⁺ entry into endothelial cells and activates BK(Ca) channels independently of GPCRs.The novel endocannabinoid receptor GPR18 is expressed in the rostral ventrolateral medulla and exerts tonic restraining influence on blood pressure.N-acyl amino acids and N-acyl neurotransmitter conjugates: neuromodulators and probes for new drug targets.Endothelial atypical cannabinoid receptor: do we have enough evidence?G protein coupled receptor 18: A potential role for endocannabinoid signaling in metabolic dysfunction.The endocannabinoid N-arachidonoyl glycine (NAGly) inhibits store-operated Ca2+ entry by preventing STIM1-Orai1 interactionBig conductance calcium-activated potassium channel openers control spasticity without sedation.Angiogenesis: a new physiological role for N-arachidonoyl serine and GPR55?The Effect of Chronic Activation of the Novel Endocannabinoid Receptor GPR18 on Myocardial Function and Blood Pressure in Conscious Rats.Abnormal cannabidiol confers cardioprotection in diabetic rats independent of glycemic control.Anandamide and endocannabinoid system: an attractive therapeutic approach for cardiovascular disease.
P2860
Q24634334-92CA2D07-BBBD-48C3-8BA8-A731ACC8FCD7Q26862515-60267F67-B825-4A12-8A05-BE8181063537Q27009735-F2BE1977-4AF8-4B20-AE29-E475C49D6EE3Q28298445-9B3003EF-8DAB-4C81-A522-7853D13E8742Q34356128-E43C6D3F-C946-44F6-9E36-3658926E289DQ35388701-1F5935B2-D9E1-4175-BA78-1068D35AAA05Q35672890-4A84198A-DA11-4A2B-BAAA-B108681595FAQ35822367-4EF84A47-97C6-4169-8858-0D0F21428D76Q36943274-9FCC4EDF-A3D2-43B4-AA59-2A021A94E47BQ37663368-96F9C907-21E2-4C1E-B96F-CD55AC1A1450Q37774694-56329137-033C-4CF6-B8C8-4B952D70AEF2Q38235155-ED07F813-A889-451F-93C5-9466F6F21A1FQ38580287-C3D65279-1897-4031-9A4F-53985DE11C66Q39226362-382E0708-973B-4C9E-BEA0-7E516F7D894EQ41098063-B3A74CB7-BEC4-4DDD-82B1-B2B55CFD1369Q41838454-1493E596-2642-4304-8505-04C7361E35B7Q46484964-2D77FC35-5A1A-4C40-AA7B-ECC32DD2C0D5Q49601942-65DE46D2-25FF-4887-AD6C-353E9245EFB7Q55487760-DEBA811F-3401-4B35-94AC-E59887DE76E9
P2860
N-arachidonoyl glycine, an endogenous lipid that acts as a vasorelaxant via nitric oxide and large conductance calcium-activated potassium channels.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
2010年论文
@zh
2010年论文
@zh-cn
name
N-arachidonoyl glycine, an end ...... -activated potassium channels.
@en
N-arachidonoyl glycine, an end ...... -activated potassium channels.
@nl
type
label
N-arachidonoyl glycine, an end ...... -activated potassium channels.
@en
N-arachidonoyl glycine, an end ...... -activated potassium channels.
@nl
prefLabel
N-arachidonoyl glycine, an end ...... -activated potassium channels.
@en
N-arachidonoyl glycine, an end ...... -activated potassium channels.
@nl
P2860
P1476
N-arachidonoyl glycine, an end ...... -activated potassium channels.
@en
P2093
Neelam Parmar
W-S Vanessa Ho
P2860
P304
P356
10.1111/J.1476-5381.2009.00622.X
P407
P577
2010-02-05T00:00:00Z